SP Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.9M | Sell |
115,492
-1,613
| -1% | -$186K | 1.23% | 21 |
|
|
2025
Q4 | $12.3M | Sell |
117,105
-1,100
| -0.9% | -$103K | 0.97% | 26 |
|
|
2025
Q3 | $9.92M | Sell |
118,205
-1,782
| -1% | -$147K | 0.79% | 29 |
|
|
2025
Q2 | $9.5M | Sell |
119,987
-5,487
| -4% | -$436K | 0.78% | 30 |
|
|
2025
Q1 | $11.3M | Buy |
125,474
+15,977
| +15% | +$1.49M | 0.99% | 25 |
|
|
2024
Q4 | $10.9M | Buy |
109,497
+3,308
| +3% | +$341K | 0.91% | 27 |
|
|
2024
Q3 | $12.1M | Buy |
106,189
+311
| +0.3% | +$36.9K | 1% | 25 |
|
|
2024
Q2 | $13.1M | Buy |
105,878
+1,691
| +2% | +$218K | 1.19% | 24 |
|
|
2024
Q1 | $13.7M | Sell |
104,187
-665
| -0.6% | -$82K | 1.28% | 25 |
|
|
2023
Q4 | $11.4M | Buy |
104,852
+697
| +0.7% | +$72.3K | 1.17% | 27 |
|
|
2023
Q3 | $10.7M | Buy |
104,155
+270
| +0.3% | +$29.1K | 1.2% | 26 |
|
|
2023
Q2 | $12M | Buy |
103,885
+660
| +0.6% | +$74.9K | 1.34% | 25 |
|
|
2023
Q1 | $11M | Sell |
103,225
-393
| -0.4% | -$42.4K | 1.35% | 25 |
|
|
2022
Q4 | $11.5M | Buy |
103,618
+30
| +0% | +$3.07K | 1.54% | 24 |
|
|
2022
Q3 | $8.92M | Buy |
103,588
+702
| +0.7% | +$62.7K | 1.22% | 25 |
|
|
2022
Q2 | $9.38M | Sell |
102,886
-2,391
| -2% | -$212K | 1.2% | 25 |
|
|
2022
Q1 | $8.64M | Buy |
105,277
+518
| +0.5% | +$40.8K | 0.93% | 31 |
|
|
2021
Q4 | $8.58M | Buy |
104,759
+18
| +0% | +$1.43K | 0.86% | 32 |
|
|
2021
Q3 | $8.54M | Buy |
104,741
+833
| +0.8% | +$63.4K | 0.89% | 31 |
|
|
2021
Q2 | $8.09M | Sell |
103,908
-3,681
| -3% | -$274K | 0.89% | 29 |
|
|
2021
Q1 | $7.8M | Buy |
107,589
+5,820
| +6% | +$429K | 0.97% | 26 |
|
|
2020
Q4 | $7.36M | Buy |
101,769
+25,739
| +34% | +$1.97M | 1.01% | 24 |
|
|
2020
Q3 | $5.84M | Buy |
76,030
+2,966
| +4% | +$232K | 0.9% | 25 |
|
|
2020
Q2 | $5.39M | Buy |
73,064
+7,281
| +11% | +$548K | 1.13% | 22 |
|
|
2020
Q1 | $4.83M | Sell |
65,783
-496
| -0.7% | -$39K | 1.31% | 20 |
|
|
2019
Q4 | $5.75M | Buy |
66,279
+259
| +0.4% | +$21.3K | 1.32% | 18 |
|
|
2019
Q3 | $5.3M | Buy |
66,020
+408
| +0.6% | +$32.7K | 1.36% | 19 |
|
|
2019
Q2 | $5.25M | Buy |
65,612
+394
| +0.6% | +$30.2K | 1.34% | 19 |
|
|
2019
Q1 | $5.18M | Buy |
65,218
+447
| +0.7% | +$33.4K | 1.41% | 18 |
|
|
2018
Q4 | $4.72M | Sell |
64,771
-91
| -0.1% | -$6.42K | 1.44% | 19 |
|
|
2018
Q3 | $4.42M | Buy |
64,862
+380
| +0.6% | +$24.2K | 1.26% | 22 |
|
|
2018
Q2 | $3.93M | Buy |
+64,482
| New | +$3.64M | 1.07% | 23 |
|
Other funds holding MRK
VCM
VPM
SP Asset Management's MRK Position: Q1 2026 in Review
SP Asset Management reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $186K and leaving 115,492 shares worth $13.9M. The position accounts for 1.23% of the portfolio, ranked #21.
SP Asset Management first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- SP Asset Management held 115,492 shares of Merck worth $13.9M as of Q1 2026.
- SP Asset Management sold 1,613 Merck shares in Q1 2026, an estimated $186K.
- Merck made up 1.23% of SP Asset Management's portfolio in Q1 2026, its #21 holding.
- SP Asset Management first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on SP Asset Management's 13F filing for Q1 2026, filed 7 May 2026.